150 related articles for article (PubMed ID: 11123274)
1. Autoantigenic HCgp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cells.
Patil NS; Hall FC; Drover S; Spurrell DR; Bos E; Cope AP; Sonderstrup G; Mellins ED
J Immunol; 2001 Jan; 166(1):33-41. PubMed ID: 11123274
[TBL] [Abstract][Full Text] [Related]
2. Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies.
Steenbakkers PG; Baeten D; Rovers E; Veys EM; Rijnders AW; Meijerink J; De Keyser F; Boots AM
J Immunol; 2003 Jun; 170(11):5719-27. PubMed ID: 12759455
[TBL] [Abstract][Full Text] [Related]
3. Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages.
Tsark EC; Wang W; Teng YC; Arkfeld D; Dodge GR; Kovats S
J Immunol; 2002 Dec; 169(11):6625-33. PubMed ID: 12444176
[TBL] [Abstract][Full Text] [Related]
4. Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint.
van Lierop MJ; den Hoed L; Houbiers J; Vencovsky J; Ruzickova S; Krystufkova O; van Schaardenburg M; van den Hoogen F; Vandooren B; Baeten D; De Keyser F; Sønderstrup G; Bos E; Boots AM
Arthritis Rheum; 2007 Jul; 56(7):2150-9. PubMed ID: 17599744
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides.
Muntasell A; Carrascal M; Serradell L; Veelen Pv Pv; Verreck F; Koning F; Raposo G; Abián J; Jaraquemada D
J Immunol; 2002 Nov; 169(9):5052-60. PubMed ID: 12391221
[TBL] [Abstract][Full Text] [Related]
6. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles.
Cope AP; Patel SD; Hall F; Congia M; Hubers HA; Verheijden GF; Boots AM; Menon R; Trucco M; Rijnders AW; Sønderstrup G
Arthritis Rheum; 1999 Jul; 42(7):1497-507. PubMed ID: 10403279
[TBL] [Abstract][Full Text] [Related]
7. Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.
Hall FC; Rabinowitz JD; Busch R; Visconti KC; Belmares M; Patil NS; Cope AP; Patel S; McConnell HM; Mellins ED; Sonderstrup G
Eur J Immunol; 2002 Mar; 32(3):662-70. PubMed ID: 11857340
[TBL] [Abstract][Full Text] [Related]
8. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation.
Fallas JL; Tobin HM; Lou O; Guo D; Sant'Angelo DB; Denzin LK
J Immunol; 2004 Aug; 173(3):1549-60. PubMed ID: 15265882
[TBL] [Abstract][Full Text] [Related]
10. Functional HLA-DM on the surface of B cells and immature dendritic cells.
Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
[TBL] [Abstract][Full Text] [Related]
11. Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulation.
Boots AM; Hubers H; Kouwijzer M; den Hoed-van Zandbrink L; Westrek-Esselink BM; van Doorn C; Stenger R; Bos ES; van Lierop MJ; Verheijden GF; Timmers CM; van Staveren CJ
Arthritis Res Ther; 2007; 9(4):R71. PubMed ID: 17645792
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
13. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
[TBL] [Abstract][Full Text] [Related]
14. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice.
Touloukian CE; Leitner WW; Topalian SL; Li YF; Robbins PF; Rosenberg SA; Restifo NP
J Immunol; 2000 Apr; 164(7):3535-42. PubMed ID: 10725708
[TBL] [Abstract][Full Text] [Related]
15. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
Muczynski KA; Anderson SK; Pious D
J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
[TBL] [Abstract][Full Text] [Related]
16. Inducible heat shock protein 70 promotes myelin autoantigen presentation by the HLA class II.
Mycko MP; Cwiklinska H; Szymanski J; Szymanska B; Kudla G; Kilianek L; Odyniec A; Brosnan CF; Selmaj KW
J Immunol; 2004 Jan; 172(1):202-13. PubMed ID: 14688327
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.
Hill JA; Southwood S; Sette A; Jevnikar AM; Bell DA; Cairns E
J Immunol; 2003 Jul; 171(2):538-41. PubMed ID: 12847215
[TBL] [Abstract][Full Text] [Related]
18. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
[TBL] [Abstract][Full Text] [Related]
19. Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells.
Greening JE; Tree TI; Kotowicz KT; van Halteren AG; Roep BO; Klein NJ; Peakman M
Diabetes; 2003 Mar; 52(3):717-25. PubMed ID: 12606513
[TBL] [Abstract][Full Text] [Related]
20. The impact of H2-DM on humoral immune responses.
Alfonso C; Han JO; Williams GS; Karlsson L
J Immunol; 2001 Dec; 167(11):6348-55. PubMed ID: 11714799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
